Last reviewed · How we verify

NCT03303417: KIWI

Effect of Kiwifruit on Gastrointestinal Fluid Distribution and Transit in Healthy Volunteers

Completed NA Results posted Last updated 17 June 2019
What this trial tests

NA trial testing MRI Scan in Constipation in 16 participants. Completed in 1 June 2018.

Timeline
27 June 2017
Primary endpoint
1 November 2017
1 June 2018

Quick facts

Lead sponsorUniversity of Nottingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment16
Start date27 June 2017
Primary completion1 November 2017
Estimated completion1 June 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

Adults 18 to 65, any sex, with Constipation or Diet Modification. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Relaxation Time in Ascending Colon Primary · 0 - 8 hours

Area under curve of Ascending colon T1 measured on MRI , in milliseconds. Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention

GroupValue95% CI
Kiwifruit312± 92
Control256± 97
Small Bowel Water Content Measured by MRI, in mL Secondary · 0 - 8 hours

Area under the curve of change of small bowel water, 0-8 hours, measured by MRI, in mL Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention

GroupValue95% CI
Kiwifruit85530± 34923
Control35023± 15557
Colonic Volume Secondary · 0 - 8 hours

Ascending (AC), transverse (TC) and descending (DC) colonic volumes, measured by MRI, in mL Data given: AUC for total colon Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention

GroupValue95% CI
Kiwifruit283583± 59402
Control243182± 46682
Colonic Transit Time Secondary · 24hr

Transit of markers through gut as assessed by the weighted average position score (total score 0-7, calculated from a score of 0-7 of each of the 5 marker pills) at 24 h on MRI A lower score indicates faster transit.

GroupValue95% CI
Kiwifruit0.80 – 1.4
Control1.00.5 – 3.1
Bowel Habit Secondary · 7 days

Assessment, via Diary, of bowel frequency Data given: stool frequency

GroupValue95% CI
Kiwifruit1.46± 0.66
Control1.14± 0.46

Sponsor's own description

Constipation is a widespread and common problem in which a person finds it difficult and/or painful to open their bowels. The current treatment is the use of medications called laxatives. Kiwifruit is a widely available food that has been shown to possess some laxative properties. The cause of this is unknown. Non-invasive medical imaging techniques such as Magnetic Resonance Imaging now allow taking pictures of the gut and its contents. The Nottingham GI MRI research group specialises in these techniques and in this study use such images to assess the changes induced in the gut contents by kiwifruit to improve understanding of how it helps patients with constipation. The volunteers will be asked to undergo 2 studies in which they take either kiwifruit or placebo (sugary drink) two times a day for 2 days and then spend a study day where will they will be fed some more kiwifruit/placebo and some normal food and image their gut at intervals. Participants will be asked to complete a stool diary to determine if they experience a laxative effect.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers.
    Wilkinson-Smith V, Dellschaft N, Ansell J, Hoad C, et al · · 2019 · cited 39× · PMID 30706488 · DOI 10.1111/apt.15127

Verify or expand the search:

Other trials of MRI Scan

Trials testing the same drug.

Other recruiting trials for Constipation

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03303417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing